首页> 外文期刊>The pharmaceutical journal >We must not let Europe slow down the pace of British POM-to-P switches
【24h】

We must not let Europe slow down the pace of British POM-to-P switches

机译:我们绝不能让欧洲放慢英国POM到P交换的步伐

获取原文
获取原文并翻译 | 示例
           

摘要

ALTHOUGH everyone thinks of ibuprofen or loperamide as the first switches from prescription-only medicines to pharmacy medicines, the era started with terfenadine, which was the first new drug to get a pharmacy only (P) classification. It happened through a simple regulatory mechanism. Under UK law, all medicines are P medicines unless they meet the criteria to be classified as POMs or general sale list medicines, when they are put on the relevant list. Until then their legal status is defined through the marketing authorisation only.
机译:尽管每个人都认为布洛芬或洛哌丁胺是从仅处方药转向药房药的第一个转变,但时代始于特非那定,后者是第一个获得仅药房(P)分类的新药。这是通过简单的监管机制实现的。根据英国法律,所有药物均应列为P药品,除非它们符合相关标准,被列为POM或一般销售清单药物。在此之前,仅通过营销授权来定义其法律地位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号